Report
Patrick Artus

Before and after the COVID vaccine: Two very different analyses

As long as there is neither a vaccine nor an effective treatment against COVID, economic activity in OECD countries depends on the evolution of the pandemic. There is a clear risk that the increase in the number of cases will cause activity - and therefore equity markets - to fall again in the fourth quarter of 2020 and the first quarter of 2021. Once there is a vaccine and effective treatment, the analysis to be made becomes very different: we will have to ask ourselves what will be irreversible and what will be permanently different. This includes: Permanent changes in behaviour (consumption, production, travel); An acceleration of the energy transition; A deterioration in corporate balance sheets. These irreversibilities will prevent a return to the pre-COVID economic situation.
Provider
Natixis
Natixis

Based across the world’s leading financial centers, Natixis CIB Research offers an integrated view of the markets. The team provides support to inform Natixis clients’ investment and hedging decisions across all asset classes.

 

Analysts
Patrick Artus

Other Reports from Natixis

ResearchPool Subscriptions

Get the most out of your insights

Get in touch